After receiving the flu vaccine, people sometimes experience achy muscles, fever, headaches, and pain at the injection site.
Moderna's mRNA flu vaccine could be approved by August, but federal policy and a nonfunctional advisory committee threaten ...
23don MSN
FDA approves world's first mRNA-based flu vaccine, signaling start of a new illness-prevention era
The vaccine, intended for people 50 and older, is based on mRNA technology and was found in an advanced trial to be more effective than a standard flu shot.
A new kind of flu vaccine is moving a step closer to the U.S. market.
In a typical year, the process of bringing a new seasonal flu shot to market is one of the United States’ most predictable vaccine routines. This, however, is not a typical year. Vaccine manufacturers ...
VRBPAC endorsed mRNA-1010 for adults 50-64 and ≥65 years, unanimously concluding benefits outweighed risks, supporting a late-stage regulatory path toward potential first mRNA seasonal influenza ...
WASHINGTON — A new kind of flu vaccine moved a step closer to the U.S. market Thursday as federal health advisers recommended approval of the first made with the same mRNA technology that was key to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results